Richard Bungay

Richard Bungay currently serves as Chief Operating Officer at Sitala Bio, a position held since January 2025. Additionally, Richard is a Non-Executive Director at Monument Therapeutics, Cambridge Cognition Plc, and Chroma Therapeutics, with the latter role continuing a long tenure that began in 2004 as Chief Financial Officer and later Chief Executive Officer. Previous roles include Chief Executive Officer at Imophoron Ltd and Diurnal Ltd, where Richard transitioned from CFO to CEO. Richard also held various leadership positions, including CFO and COO at Mereo BioPharma and CFO at Verona Pharma PLC. Richard's early career included a role as Director of Corporate Communications and Strategic Planning at Celltech Group plc. Richard holds a Bachelor's degree in Chemistry from the University of Nottingham.